Neurons, astrocytes, and microglia are three of the main cell types present in the central nervous system (CNS). They are the central focus of attention in the study of CNS physiology and the development of neurological pathologies including Alzheimers' disease (AD), Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS) among others [1] [2] [3] [4] [5] . Numerous in vitro neuronal models rely upon the culture of these cells on plastic or glass-based surfaces. These 2D platforms, however, are poor representations of the natural cell milieu since they fail to recapitulate key aspects of the 3D microarchitecture of native tissue 6 . In addition, cells in 2D models experience surfaces with rigidity values orders of magnitude greater than the rigidity present in native tissue. Moreover, in 2D environments the presence of diffusional limitations for the exchange of nutrients, waste products, or the accumulation of extracellular matrix (ECM) components is either restricted or nonexistent 7 . This drawback directly restrains studies focused on the production and accumulation of amyloid beta or tau proteins, both of which are the most recognized ECM indicators of AD progression [8] [9] . In short, cellular responses procured from 2D platforms cannot be directly extrapolated into 3D contexts 10 . Therefore, there is still a need for the development of novel scaffolds with the capacity to support the 3D culture of human CNS cells.
Ideally, 3D scaffolds should have the capacity to be fine-tuned to recapitulate similar chemical and mechanical properties to those of central nervous tissue.
Multicomponent interpenetrating networks (mIPNs) offer a promising alternative to these demands as they have the potential to present mechanically compliant scaffolds whose high water content and chemical composition resembles soft tissue 11 . While numerous approaches have been taken to utilize mIPN hydrogels to address the demand for biocompatible 3D neural scaffolds, only a few studies have tailored their biomaterials towards multiple neural cell types [12] [13] . In this work, our team developed, characterized and evaluated a new family of mIPNs as potential 3D scaffolds for the culture of human CNS cells. Since obtaining neurons in high numbers is challenging, we used neural stem cells as one of our cell models. These cells have the capacity to differentiate into neuron-like cells in large quantities 6, 14 . Neural stem cells (Human iPSC-Derived Neural Stem Cells, iHNSCs) were commercially obtained from Cell Applications and used at passage four. In addition to neural stem cells, we also utilized human astrocytes (HAf, Cell Applications) at passage five, and the human microglia cell line (HMC3, ATCC) as our cell models. The three cell types were cultured and expanded in vitro following the general recommendation and culture protocols provided by the seller. The proposed bioinspired mIPNs were fabricated using collagen type I (Col I, BD Biosciences), hyaluronic acid (HA, Lifecore Biomedical, 1,300 kDa) and poly(ethylene glycol) diacrylate (PEGDA, Sigma) of varying molecular weights (MW).
Although these three components have been extensively utilized as hydrogel scaffolds in biomedical applications, to the best of our knowledge, this is the first time they have been combined in a sequential fashion to fabricate mIPN structures that support the 3D culture of three of the main cell types in the CNS.
Collagen I was selected due to its self-assembling properties, its similar chemical composition to collagen type IV, the primary collagen type in the CNS, and because it has been previously employed in modeling in vitro systems of brain tissue 15 . Hyaluronic acid was chosen because it is the most abundant polysaccharide in CNS tissue 15 and because it plays an integral role in the physiology of the CNS 16 .
Finally, PEGDA was also employed due to its well established biocompatibility, its biological blank slate behavior, its resistance to cell mediated contraction and degradation 17 , and because, by varying its concentration and MW, the overall mechanical performance of the scaffolds can be fine-tuned [18] [19] [20] [21] .
PEGDA of varying MW was synthesized following the methods described by Jimenez-Vergara et al. 18 .
To fabricate the mIPNs scaffolds described in Table 1 , we first assembled a semi-IPN structure using Col I at 3.0 mg/mL and HA from 0.0 to 2.0 mg/mL. The selected values for the Col I and HA concentrations have been previously used in other hydrogels systems 17, [22] [23] . Three independent encapsulation experiments were performed (one per cell type). In brief, undifferentiated iHNSCs, HAf or HMC3 cells were suspended in an ice-cold Col I-HA solution (pH ≈ 7.2) at 7.5E05 cell/mL, and then 300 μL of the cell suspension were placed in 12-well plate inserts and allowed to crosslink at 37 ⁰C. At neutral pH and 37 ⁰C, Col I molecules self-assemble into fiber structures physically entrapping the HA molecules [24] [25] . Since both Col I and HA are susceptible to cell mediated contraction and degradation, PEGDA was introduced by sequential infiltration following the methods described by Munoz-Pinto et al. to increase the mechanical and physical stability of the scaffolds 17 . In brief, 1.7 mL of PEGDA solution at 8.24%, The measurements of the complex modulus served as an indirect method to assess the equilibrium for the infiltration of PEGDA molecules. The mIPN7 was selected as a model for this assessment because this formulation contains the highest levels of HA and therefore the highest resistance to diffusion among the testing group. The complex modulus was measured using a TA Instruments Electroforce 3100 mechanical tester. Eight millimeter diameter disks with approximate 1 mm in height were preloaded with a 2 g force, indented 100 µm, and with an oscillation amplitude of 100 µm. All statistical analyses of the experimental results in this work were performed using analysis of variance (ANOVA) with the Tukey's post hoc test.
Significant differences between groups were identified and highlighted for p ≤ 0.05 (IBM SPSS software). To gain insight into the microscopic structure of the proposed mIPNs, we performed scanning electron microscopy (SEM) using a JEOL JSM-6010LA Scanning Electron Microscope on the mIPN7 which contains 3.0 mg/mL Col I, 2.0 mg/mL HA and 7.0% w/w 3.4 kDa PEGDA. Appropriate controls including a pure Col I, pure PEGDA, and Col I-PEGDA hydrogels were also imaged. The mIPN7 and the controls were fabricated and allowed to swell for 24 h, the specimens were prepared for imaging following a modified protocol from Raub et al. 22 . In brief, the hydrogel specimens were fixed with 10.0% v/v formalin and dehydrated using ethanol and hexamethyldisilazane. Following the dehydration procedure the samples were cut into two pieces and allowed to dry for 24 h. The samples were then stored until use in a desiccator. Prior to imaging, specimens were mounted on SEM sample stages using carbon tape and sputter coated with gold to a thickness of 6 nm using a Cressington 208auto sputter coater. SEM micrographs (n = 5) were taken from the cross-sectional area of each specimen at 5.0 kV and 7,000x magnification. Representative micrograph images are shown in Figure 2 . The microscopic landscape of the mIPN ( Figure 2D ) displayed increasing packing when compared to the Col I-PEGDA, the pure Col I or PEGDA hydrogels ( Figure 2C , 2A and 2B) controls. The resulting mIPN microenvironment differs significantly from the pure Col I network which displays the characteristic fiber structures (Figure 2A) , and the pure PEGDA network characterized by a dense mesh-like architecture. The addition of HA to the double Col I-PEGDA networks appears to increase packing density of the scaffold.
The presence of Col I and HA was qualitatively confirmed after 14 days using Picrosirius Red (PR, Polysciences) and Alcian Blue (AB, Acros Organics) staining respectively ( Figure 3 ). The 14 day time point has been previously used to evaluate the integrity of similar IPN systems 17 . As expected, the red coloration in the hydrogels was observed in the formulation containing Col I and not significantly detected in the pure PEGDA hydrogel. In addition, the intensity of the blue color increased as the HA content increased in the hydrogels from the 0.0 mg/mL HA in the PEGDA and mIPN2 to the 2.0 mg/mL HA in the mIPN7. Furthermore, using visible absorbance spectroscopy, following a modified approach from Frazier et al. 27 , the HA levels in the mIPN7 were also quantitatively evaluated confirming a total HA concentration of approximately 2.1 ± 0.2 mg/mL (n = 3). In brief, HA standards and mIPN7 hydrogel samples were digested in 0.1 N NaOH and 37 °C for 72 h. A volume of 100 μL of the digested samples or standards solutions were placed in contact with a 1.0 mg/mL AB in 3.0% v/v acetic acid solution. The resulting mixture was incubated at room temperature for 30 min, and then centrifuged at 10,000 rpm for 5 min. The supernatant was removed and the pellet dissolved in 400 μL of the Blyscan dissociation reagent (Accurate Chemical). The absorbance of each sample and standard was read at 680 nm using a SpectraMax M4 multi-mode microplate reader. The concentration of HA in the samples was calculated by interpolating the absorbance reading in the standard curve. Cumulatively, the microscopic characterization, the staining, and the spectroscopy confirmed the presence of the three network components in the mIPNs.
In terms of mechanical performance, the complex modulus of the mIPN formulations shown in Table 1 was evaluated and compared with the viscoelastic properties of the cortex of mouse brain (MB). [17] [18] [19] 28 . In Figure   4A , the complex modulus of the mIPN containing 20.0 kDa PEGDA (mIPN1) was 4.2 kPa while the mIPN2 (10.0 kDa PEGDA) exhibited a modulus of 7.4 kPa. The modulus of the mIPN1 was significantly lower than the modulus in the MB tissue or the mIPN2 (p ≤ 0.028). The mechanical performance of the mIPN3, mIPN4, and mIPN5 is shown in Figure 4B . These formulations which contain 1.0 mg/mL HA and 7.0 to 8.0% w/w PEGDA 3.4 kDa or 6.0 kDa did not exhibit significant differences in terms of complex modulus when compared to MB tissue (p ≥ 0.247). The complex modulus of scaffolds containing HA at 2.0 mg/mL and 3.4 kDa PEGDA at 7.0 to 8.0% w/w is presented in Figure 4C . In this series mIPN, formulations containing 3.4 kDa PEGDA levels at 8.0% w/w or higher concentration displayed significantly higher values of complex modulus when compared to MB tissue (p = 0.003). Finally, Figure   4D summarizes the mechanical performance of three mIPN formulations exhibiting similar complex modulus to that measured in MB (≈ 6.9 kPa), while allowing the modulation of the HA content from 0.0 to 2.0 mg/mL. These findings are very significant since, by modulating the MW and concentration of PEGDA, the mechanical properties of the mIPNs can be adjusted to mimic the modulus of brain tissue while the content of biochemical cues such as HA can be varied. Differences in the biochemical content in the mIPNs can then be used to study processes such as tissue degradation or tissue scarring.
Thus far, we have demonstrated that the chemical composition of the bioinspired mIPNs can be modulated to achieve a family of materials exhibiting complex moduli within a relevant range of values of CNS tissue. While the presence of Col I and HA provides biochemical cues, PEGDA was introduced to maintain mechanical stability and to limit cell-mediated contraction and degradation 17 . Our final goal was to highlight that our fabrication procedure resulted in a cytocompatible system that supports the 3D
in vitro culture of human neural stem cell, astrocytes and microglia. Toward this end, the Live/Dead viability assay (Invitrogen) was performed 24 h post cell encapsulation in the mIPN7 formulation as shown in Figure 5 . At least four regions from four independent specimens were imaged using a laser Nikon A1 confocal microscope system. Cell counts were obtained using Image J and the viability reported as the ratio between living cells and the total number of cells ( Figure 5A ). Representative images of the cell viability assay are reported in Figure 5B . Cell viability for iHNSCs, HAf, and HMC3 24 h post scaffold fabrication was 84%, 93%, and 89% respectively. The viability of the iHNSCs was the lowest among the three evaluated cell types. This observation can be explained if we consider that stem cells are more sensitive than non-stem cells, and that they require very specific substrates and cell culture conditions for their growth and maintenance. The viability of the scaffolds could be further enhanced by introducing additional ECM components such as laminin or laminin-based peptide sequences 29 . The overall viability results demonstrated that the mIPNs are very promising scaffolds which can sustain at least 84% cell viability. These results are within the range of values previously reported for hydrogel based systems 30 .
Cumulatively, we have demonstrated that in the proposed family of mIPNs the chemical composition can be adjusted to achieve complex moduli within the range of mechanical properties of CNS tissue. The SEM characterization, PR and AB staining, and absorbance spectroscopy confirmed the incorporation of the three components. Finally, encapsulated human astrocytes, microglia, and neural stem cells exhibited very good viability values which exceed 84%. We believe that this proposed platform could potentially be used as an in vitro 3D model for studying the physiology and the progression of pathologies associated with three of the main cells types in the CNS. In addition, we also envision that the 3D context provided by the mIPNs could potentially aid in understanding some of the molecular mechanisms responsible for the production and accumulation of ECM components, such as amyloid beta and the tau protein, and their effects on the behavior of neuron-like cells, astrocytes, and microglia.
Moreover, since the presence of Col I has been associated with astrocyte reactivity and HA with the promotion of quiescent astrocytes 23 , the fine tuning of the Col I-HA ratio in the scaffolds could be used to study glial scar formation. Therefore, our mIPNs offer the opportunity to study the astrocyte reactivity that is characteristic of the brain inflammation preceding and during AD neurodegeneration. In summary, the continuous development of these novel scaffolds will be of great interest to the neuroscience and the Alzheimer's research community.
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